Related Experiment Video

Updated: May 22, 2026

Real-Time Polymerase Chain Reaction-Based Detection and Quantification of Hepatitis B Virus DNA
04:11

Real-Time Polymerase Chain Reaction-Based Detection and Quantification of Hepatitis B Virus DNA

Published on: December 15, 2023

[Pathological grading analysis of liver biopsies in chronic hepatitis B virus carriers of different age ranges]

Chun-xia Yang1, Wei-bo Yang, Jing-hua Fan

  • 1Department of Infectious Diseases, the First Affiliated Hospital of Kunming Medical College, Kunming 650032, China.

Zhonghua Gan Zang Bing Za Zhi = Zhonghua Ganzangbing Zazhi = Chinese Journal of Hepatology
|April 25, 2012
PubMed

Insights

For chronic hepatitis B (HBV) carriers, liver biopsy is most informative for patients aged 30 and older. This age group shows higher rates of significant liver inflammation or fibrosis, aiding treatment decisions.

Area of Science:

  • Hepatology
  • Virology
  • Gastroenterology

Context:

  • Chronic hepatitis B virus (HBV) infection affects millions globally.
  • Liver biopsy remains a crucial diagnostic tool for assessing disease severity in chronic HBV carriers.
  • Optimal timing for liver biopsy in relation to patient age and disease progression is not well-defined.

Purpose:

  • To determine the optimal age range for performing liver biopsy in chronic HBV carriers.
  • To correlate liver histopathology findings (inflammation and fibrosis) with age groups in chronic HBV carriers.
  • To guide antiretroviral treatment decisions based on age-appropriate biopsy timing.

Summary:

  • A study analyzed liver biopsy results from 292 chronic HBV carriers, categorized into three age groups (11-29, 30-39, and 40-60 years).
  • Higher percentages of significant liver inflammation (G2) or fibrosis (S2) were observed in older age groups, particularly those 30 years and above.
  • The findings indicate that liver biopsy is more informative for chronic HBV carriers aged 30 and older.

Impact:

  • Provides evidence-based recommendations for the timing of liver biopsy in chronic HBV management.
  • Aids clinicians in optimizing diagnostic strategies for chronic HBV carriers.
  • Contributes to more accurate staging of liver disease and personalized treatment planning.
Abstract

More Related Videos

"Liver-on-a-Chip" Cultures of Primary Hepatocytes and Kupffer Cells for Hepatitis B Virus Infection10:25

"Liver-on-a-Chip" Cultures of Primary Hepatocytes and Kupffer Cells for Hepatitis B Virus Infection

Published on: February 19, 2019

Determining Bile Duct Density in the Mouse Liver07:35

Determining Bile Duct Density in the Mouse Liver

Published on: April 30, 2019

Related Concept Videos

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
Cirrhosis I: Introduction01:23

Cirrhosis I: Introduction

Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Liver Histology01:27

Liver Histology

The microscopic anatomy of the liver is a complex and intricate system that comprises numerous structural units known as liver lobules, each of which is comparable in size to a sesame seed. These hexagonal structures consist of plates of liver cells or hepatocytes, which are characterized by their versatility and abundance of cellular apparatus like rough and smooth ER, Golgi apparatus, peroxisomes, and mitochondria.
Hepatocytes perform a variety of essential functions. They secrete...
Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...